Skip to content
Events

Details

How to make community access a pillar of advanced care and wellness

Many healthcare organizations have yet to realize the promise of precision medicine. Henry Ford Health System, however, has made tremendous strides. The Henry Ford Jeffries Center for Precision Medicine provides access to comprehensive genomic testing and associated clinical support for all patients — and that is just the beginning. Hear more about the health system's precision medicine journey during this session.

Speakers
Tom Mikkelsen

Tom Mikkelsen, MD, FRCP©
Medical Director
Jeffries Center for Precision Medicine and Clinical Trials,
Henry Ford Health System

Louisa Laidlaw

Louisa Laidlaw
(Former) Administrative Director
Jeffries Center for Precision Medicine,
Henry Ford Health System

Damon Hostin

Damon Hostin
Senior Director, Market Access
Illumina

Date & Time
Apr 27, 2022
11:35 AM - 12:15 PM
Location
Hyatt Regency
Chicago, Illinois
Live in-person event
Sponsor
Becker's Hospital Review
Topic
Complex disease genomics
This event has passed

Related Events

Feb 26
Illumina’s Integrated Workflow for Rare and Undiagnosed Genetic Disease Research
Feb 26, 2025
Individuals suspected of having a rare disease often face a long search for an answer. With up to 80% of rare diseases being genetic or having a genetic subtype, it is imperative to interrogate the genome to find answers and shorten the diagnostic odyssey. This webinar provides an overview of the integrated workflow provided by Illumina for rare and undiagnosed diseases research. Starting from library prep to sequencing and informatics, Illumina empowers researchers to find the answers they seek in rare and undiagnosed disease research.
View Event
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see www.illumina.com/company/legal.html.

© 2025 Illumina, Inc. All rights reserved.